4
Changes in Ownership
Werewolf Therapeutics, Inc. Filed Acc 0000950170-25-002362
Options or other derivatives
- Chief Business Officer acquired 131,900 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Lubman Ellen Chief Business Officer | 2025-01-02 | Grant or award · Stock Option (right to buy) | +131,900 | 131,900 | D | ||
Loading xslF345X05/ownership.xml…